Biorelate
Oldham
About Biorelate
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: biorelate.com
- Phone: [email protected]
Industries & Categories
Big Data, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/biorelate-60 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.